Additionally, substantial evidence suggests that LINC01089 exhibits aberrant expression levels in multiple human cancers, such as hepatocellular carcinoma, lung cancer, and gastric tumors. This evidence concerns the gene LINC01089 and hepatocellular carcinoma.